β-Cell DNA Damage Response Promotes Islet Inflammation in Type 1 Diabetes.
| Citation | Horwitz, Elad, et al. “β-Cell DNA Damage Response Promotes Islet Inflammation in Type 1 Diabetes”. 2018. Diabetes, vol. 67, no. 11, 2018, pp. 2305–2318. |
| Center | Vanderbilt University |
| Author | Elad Horwitz, Lars Krogvold, Sophia Zhitomirsky, Avital Swisa, Maya Fischman, Tsuria Lax, Tehila Dahan, Noa Hurvitz, Noa Weinberg-Corem, Agnes Klochendler, Alvin C Powers, Marcela Brissova, Anne Jörns, Sigurd Lenzen, Benjamin Glaser, Knut Dahl-Jørgensen, Yuval Dor |
| Abstract |
Type 1 diabetes (T1D) is an autoimmune disease where pancreatic β-cells are destroyed by islet-infiltrating T cells. Although a role for β-cell defects has been suspected, β-cell abnormalities are difficult to demonstrate. We show a β-cell DNA damage response (DDR), presented by activation of the 53BP1 protein and accumulation of p53, in biopsy and autopsy material from patients with recently diagnosed T1D as well as a rat model of human T1D. The β-cell DDR is more frequent in islets infiltrated by CD45 immune cells, suggesting a link to islet inflammation. The β-cell toxin streptozotocin (STZ) elicits DDR in islets, both in vivo and ex vivo, and causes elevation of the proinflammatory molecules IL-1β and Cxcl10. β-Cell-specific inactivation of the master DNA repair gene ataxia telangiectasia mutated (ATM) in STZ-treated mice decreases the expression of proinflammatory cytokines in islets and attenuates the development of hyperglycemia. Together, these data suggest that β-cell DDR is an early event in T1D, possibly contributing to autoimmunity. |
| Year of Publication |
2018
|
| Journal |
Diabetes
|
| Volume |
67
|
| Issue |
11
|
| Number of Pages |
2305-2318
|
| Date Published |
12/2018
|
| ISSN Number |
1939-327X
|
| DOI |
10.2337/db17-1006
|
| Alternate Journal |
Diabetes
|
| PMCID |
PMC6198335
|
| PMID |
30150306
|
| Download citation |